| |
|
Metaplastic Breast Cancer |
| N (%) |
| Total |
15(100) |
| Age(years) |
Mean |
50.14 |
| |
minimum |
30 |
| |
maximum |
74 |
| Stage(p) |
|
|
| |
1 |
00(00) |
| |
2 |
09(60.0) |
| |
3 |
05(33.4) |
| |
4 |
01(6.6) |
| Neoadjuvant chemotherapy |
|
|
| 02(13.3) |
| Adjuvant chemotherapy |
|
13(86.7) |
| Trastuzumab |
|
01(6.6) |
| Surgery |
BCT |
04(26.7) |
| Mastectomy |
11(73.3) |
| |
|
| DXRT |
Yes |
13(86.7) |
| No |
02(13.3) |
| Adjuvant Hormonal |
Yes |
02(13.3) |
| No |
13(86.7) |
|
